JMI LABS IS NOW PART OF LEARN MORE

Emergence and Widespread Dissemination of OXA-23, -24 and -58 Carbapenemases Among Acinetobacter spp. in Asia-Pacific Nations (APAC): Report from the SENTRY Antimicrobial Surveillance Program (2006)

Emergence and Widespread Dissemination of OXA-23, -24 and -58 Carbapenemases Among Acinetobacter spp. in Asia-Pacific Nations (APAC): Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Turnidge JD, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

10 Years of Surveillance of Bloodstream Infections (BSI) in North American (NA) Medical Centers by the SENTRY Antimicrobial Surveillance Program (1997-2006)

10 Years of Surveillance of Bloodstream Infections (BSI) in North American (NA) Medical Centers by the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Detection of Methyltransferases (MT) Conferring High-Level Resistance (R) to Aminoglycosides (AG) in Enterobacteriaceae (ENT) from Europe, North America and Latin America

Detection of Methyltransferases (MT) Conferring High-Level Resistance (R) to Aminoglycosides (AG) in Enterobacteriaceae (ENT) from Europe, North America and Latin America, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Enterobacter spp. in the Asia-Pacific (APAC) Region: A SENTRY Antimicrobial Surveillance Program Report (2006)

Enterobacter spp. in the Asia-Pacific (APAC) Region: A SENTRY Antimicrobial Surveillance Program Report (2006), Lead author: Turnidge JD, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Dissemination of IMP-Type Metallo-β-Lactamases among Pseudomonas aeruginosa and Emergence of VIM-2 in Klebsiella oxytoca in Mexico: Report from the SENTRY Antimicrobial Surveillance Program

Dissemination of IMP-Type Metallo-β-Lactamases among Pseudomonas aeruginosa and Emergence of VIM-2 in Klebsiella oxytoca in Mexico: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Initial Occurrences of Linezolid (LZD) Resistance (R) from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program (Europe, Latin, America, Asia Pacific)

Initial Occurrences of Linezolid (LZD) Resistance (R) from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program (Europe, Latin, America, Asia Pacific), Lead author: Ross JE, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

To Split, or Not to Split a MIC Distribution, That is the Question: Setting Susceptibility Breakpoints

To Split, or Not to Split a MIC Distribution, That is the Question: Setting Susceptibility Breakpoints, Lead author: Bhavnani SM, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Detection of Antimicrobial Susceptibility Testing (AST) Errors by Automated Systems: College of American Pathologists (CAP) Microbiology Surveys Results for 2003-2006

Detection of Antimicrobial Susceptibility Testing (AST) Errors by Automated Systems: College of American Pathologists (CAP) Microbiology Surveys Results for 2003-2006, Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Critical Evaluation of Linezolid Susceptibility (S) Testing Using Two Automated Systems (Vitek, Vitek 2)

Critical Evaluation of Linezolid Susceptibility (S) Testing Using Two Automated Systems (Vitek, Vitek 2), Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Intermethod Comparability Analyses of Tigecycline Antimicrobial Susceptibility Tests (AST) Using over 5,000 Pathogens Isolated in Asia-Pacific Countries

Intermethod Comparability Analyses of Tigecycline Antimicrobial Susceptibility Tests (AST) Using over 5,000 Pathogens Isolated in Asia-Pacific Countries, Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Proposed Disk Diffusion (DD) Quality Control (QC) Ranges for Ulifloxacin (ULI) and Intermethod Comparison Using CLSI Broth Microdilution and DD

Proposed Disk Diffusion (DD) Quality Control (QC) Ranges for Ulifloxacin (ULI) and Intermethod Comparison Using CLSI Broth Microdilution and DD, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Selection of a Surrogate Carbapenem (CARB) Testing Agent for Initial Susceptibility (S) Testing of Doripenem (DOR)

Selection of a Surrogate Carbapenem (CARB) Testing Agent for Initial Susceptibility (S) Testing of Doripenem (DOR), Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Re-Evaluations of H. influenzae (HI) Susceptibility (S) Tests for Penicillins ± β-Lactamase Inhibitors against β-Lactamase-Negative Ampicillin-Resistant (BLNAR) Strains: a SENTRY Program Report

Re-Evaluations of H. influenzae (HI) Susceptibility (S) Tests for Penicillins ± β-Lactamase Inhibitors against β-Lactamase-Negative Ampicillin-Resistant (BLNAR) Strains: a SENTRY Program Report, Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

In Vitro Evaluation of TD-1792; a Novel Antimicrobic with Potent Gram-Positive Activity

In Vitro Evaluation of TD-1792; a Novel Antimicrobic with Potent Gram-Positive Activity, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

In Vitro Activity of Ulifloxacin Tested against a Worldwide Collection of Pathogens Producing Traveler’s Diarrhea

In Vitro Activity of Ulifloxacin Tested against a Worldwide Collection of Pathogens Producing Traveler’s Diarrhea, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Antimicrobial Activity of Omiganan Pentahydrochloride against Contemporary (2005-2006) Gram-Negative Pathogens Responsible for Local Catheter Site Infections

Antimicrobial Activity of Omiganan Pentahydrochloride against Contemporary (2005-2006) Gram-Negative Pathogens Responsible for Local Catheter Site Infections, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Activity of Omiganan against Contemporary (2005-2006) Gram-Positive Pathogens Responsible for Catheter Colonization and Catheter-Related Bloodstream Infections

Activity of Omiganan against Contemporary (2005-2006) Gram-Positive Pathogens Responsible for Catheter Colonization and Catheter-Related Bloodstream Infections, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Doripenem Activity Tested Against Gram-Negative Pathogens in the Asia-Pacific (APAC) Region: Report from the SENTRY Antimicrobial Surveillance Program, 2006

Doripenem Activity Tested Against Gram-Negative Pathogens in the Asia-Pacific (APAC) Region: Report from the SENTRY Antimicrobial Surveillance Program, 2006, Lead author: Turnidge JD, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Antimicrobial Activity of PZ-601 (SMP-601) Tested against Selected Wildtype (WT) and Resistant (R) Collection of Targeted Species (U.S. and Europe)

Antimicrobial Activity of PZ-601 (SMP-601) Tested against Selected Wildtype (WT) and Resistant (R) Collection of Targeted Species (U.S. and Europe), Lead author: Jones RN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Activity of Ceftobiprole (BPR) Tested against Gram-Positive and -Negative Pathogens in the Asia-Pacific Region: Report from the SENTRY Antimicrobial Surveillance Program (2006)

Activity of Ceftobiprole (BPR) Tested against Gram-Positive and -Negative Pathogens in the Asia-Pacific Region: Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Bell JM, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Antimicrobial Activity of ME1036 and Ceftaroline Tested against Clinical Strains of Community-Acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA)

Antimicrobial Activity of ME1036 and Ceftaroline Tested against Clinical Strains of Community-Acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Activity of Tigecycline (TGC) Tested against Clinical Pathogens Collected in Korea, the Philippines, Singapore and Thailand (2006)

Activity of Tigecycline (TGC) Tested against Clinical Pathogens Collected in Korea, the Philippines, Singapore and Thailand (2006), Lead author: Bell JM, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Antimicrobial Activity of Iclaprim Tested against Recent Staphylococcus aureus Clinical Isolates: Results from the International Study of Iclaprim Susceptility (ISIS)

Antimicrobial Activity of Iclaprim Tested against Recent Staphylococcus aureus Clinical Isolates: Results from the International Study of Iclaprim Susceptility (ISIS), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

In Vitro Activity of Iclaprim and Comparison Agents Tested against Neisseria gonorrhoeae Including Growth Stimulating Effects

In Vitro Activity of Iclaprim and Comparison Agents Tested against Neisseria gonorrhoeae Including Growth Stimulating Effects, Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Antimicrobial Activity of a Novel Dihydrofolate Reductase, Iclaprim, Tested against Clinical Strains of Enterobacteriaceae (ENT): Results from the International Study of Iclaprim Susceptibility (ISIS)

Antimicrobial Activity of a Novel Dihydrofolate Reductase, Iclaprim, Tested against Clinical Strains of Enterobacteriaceae (ENT): Results from the International Study of Iclaprim Susceptibility (ISIS), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Comparative Evaluation of Iclaprim Potency and Bactericidal Activity Tested against Enterococci: Results from the International Study of Iclaprim Susceptibility (ISIS)

Comparative Evaluation of Iclaprim Potency and Bactericidal Activity Tested against Enterococci: Results from the International Study of Iclaprim Susceptibility (ISIS), Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

In Vitro Activity of Iclaprim, a Novel Diaminopyrimidine, Tested against &#223-Haemolytic Streptococci from the U.S. and Europe: Results from the International Study of Iclaprim Susceptibility (ISIS).

In Vitro Activity of Iclaprim, a Novel Diaminopyrimidine, Tested against &#223-Haemolytic Streptococci from the U.S. and Europe: Results from the International Study of Iclaprim Susceptibility (ISIS)., Lead author: Sader HS, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Evaluation of the Novel Ceragenin, CSA-13 Activity and Potential Synergy (SYN) against Clinical Isolates of Pseudomonas aeruginosa (PA), Including Multi-Drug Resistant PA (MDR-PA)

Evaluation of the Novel Ceragenin, CSA-13 Activity and Potential Synergy (SYN) against Clinical Isolates of Pseudomonas aeruginosa (PA), Including Multi-Drug Resistant PA (MDR-PA), Lead author: Chin JN, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Discovery of EP-014887: A Novel Oxime 3,6-Bicyclolide with High Potency against MRSA and a Favorable In Vivo Efficacy Profile

Discovery of EP-014887: A Novel Oxime 3,6-Bicyclolide with High Potency against MRSA and a Favorable In Vivo Efficacy Profile, Lead author: Tang D, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Activity of Omiganan Pentahydrochloride against Yeast and Mould Pathogens Associated with Catheter Colonization and Catheter-Related Bloodstream Infections

Activity of Omiganan Pentahydrochloride against Yeast and Mould Pathogens Associated with Catheter Colonization and Catheter-Related Bloodstream Infections, Lead author: Fritsche TR, presented at 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2007, Chicago, IL

Medium Quality and Susceptibility Testing Results of Telavancin Using CLSI Standardized Methods (M2-A9 and M7-A7)

Medium Quality and Susceptibility Testing Results of Telavancin Using CLSI Standardized Methods (M2-A9 and M7-A7), Lead author: Benton BM, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Antimicrobial Activity of Doripenem Tested Against Bloodstream Infection Isolates from North America (2003-2006)

Antimicrobial Activity of Doripenem Tested Against Bloodstream Infection Isolates from North America (2003-2006), Lead author: Fritsche TR, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Five-Year Longitudinal Assessment of Linezolid (LZD) Activity in Europe (EU): Results from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS)

Five-Year Longitudinal Assessment of Linezolid (LZD) Activity in Europe (EU): Results from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS), Lead author: Ross JE, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Secular Trends in Antimicrobial Resistance Among USA Isolates of S. pneumoniae : A Decade of Experience from the SENTRY Antimicrobial Surveillance Program

Secular Trends in Antimicrobial Resistance Among USA Isolates of S. pneumoniae : A Decade of Experience from the SENTRY Antimicrobial Surveillance Program, Lead author: Moet G, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Differential Potential for the Disinfectant Benzalkonium Chloride and the Antiseptics Chlorhexidine and Omiganan Pentahydrochloride to Serve as Resistance Selectors in the Hospital Environment

Differential Potential for the Disinfectant Benzalkonium Chloride and the Antiseptics Chlorhexidine and Omiganan Pentahydrochloride to Serve as Resistance Selectors in the Hospital Environment, Lead author: Johnson DM, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

A Multi-Site Comparison Study of the Sensititre Automated/Manual Susceptibility Plate to the CLSI Microdilution Method for Streptococcus spp.

A Multi-Site Comparison Study of the Sensititre Automated/Manual Susceptibility Plate to the CLSI Microdilution Method for Streptococcus spp., Lead author: Killian SB, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

A Multi-Site Study of a Broth D Zone Test System Using TREK Sensititre® 18-24 hour dried Susceptibility Plates for Detecting Inducible Resistance to Clindamycin in Macrolide Resistant Gram-Positive Organisms

A Multi-Site Study of a Broth D Zone Test System Using TREK Sensititre® 18-24 hour dried Susceptibility Plates for Detecting Inducible Resistance to Clindamycin in Macrolide Resistant Gram-Positive Organisms, Lead author: Miskov AM, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Dalbavancin Disk Diffusion Tests: Development Evaluations Using Various Disk Concentrations, Solvents and Surfactants

Dalbavancin Disk Diffusion Tests: Development Evaluations Using Various Disk Concentrations, Solvents and Surfactants, Lead author: Jones RN, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Comparative Results of Oxacillin and Cefoxitin Disk Diffusion Staphylococcal Tests and the Occurrence of Inducible Clindamycin Resistance in Various Gram-Positive Species: Results from a 52-Center Trial of a Novel Lipopeptide

Comparative Results of Oxacillin and Cefoxitin Disk Diffusion Staphylococcal Tests and the Occurrence of Inducible Clindamycin Resistance in Various Gram-Positive Species: Results from a 52-Center Trial of a Novel Lipopeptide, Lead author: Biedenbach DJ, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Re-Evaluation of Disk Diffusion Breakpoints for Tigecycline When Testing Enterobacteriaceae

Re-Evaluation of Disk Diffusion Breakpoints for Tigecycline When Testing Enterobacteriaceae, Lead author: Sader HS, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Feasibility Studies for Anidulafungin Disk Diffusion Susceptibility Testing of Yeast by CLSI M-44 Method

Feasibility Studies for Anidulafungin Disk Diffusion Susceptibility Testing of Yeast by CLSI M-44 Method, Lead author: Rhomberg PR, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Molecular Analysis of Resistance Markers and Clonality among Gram-negative Bacilli: Report from the 2006 MYSTIC Program (USA)

Molecular Analysis of Resistance Markers and Clonality among Gram-negative Bacilli: Report from the 2006 MYSTIC Program (USA), Lead author: Deshpande LM, presented at 107th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2007, Toronto, Ontario, Canada

Emergence and Dissemination of Metallo-Beta-Lactamases Producing Strains in Europe: Report from the SENTRY Antimicrobial Surveillance Program

Emergence and Dissemination of Metallo-Beta-Lactamases Producing Strains in Europe: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Assessment of the Polymyxin B Antimicrobial Activity Tested against 26,921 Clinical Strains of Gram-Negative Bacilli Collected in Europe: Report from 10 Years of the SENTRY Antimicrobial Surveillance Program

Assessment of the Polymyxin B Antimicrobial Activity Tested against 26,921 Clinical Strains of Gram-Negative Bacilli Collected in Europe: Report from 10 Years of the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Characterization VIM-1-Producing Pseudomonas aeruginosa, Enterobacter cloacae and Klebsiella pneumoniae Strains from Germany: Report from SENTRY Antimicrobial Surveillance Program

Characterization VIM-1-Producing Pseudomonas aeruginosa, Enterobacter cloacae and Klebsiella pneumoniae Strains from Germany: Report from SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

The Evaluation of the Bactericidal Activity of Daptomycin, Vancomycin and Linezolid and determination of the Interactions of These Antimicrobials with Gentamicin or Rifampin against S. aureus

The Evaluation of the Bactericidal Activity of Daptomycin, Vancomycin and Linezolid and determination of the Interactions of These Antimicrobials with Gentamicin or Rifampin against S. aureus, Lead author: Sader HS, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Prevalence and Antimicrobial Susceptibility Profiles of Leading Nosocomial Pneumonia Pathogens: The Ten Year Report from the European SENTRY Antimicrobial Surveillance Program

Prevalence and Antimicrobial Susceptibility Profiles of Leading Nosocomial Pneumonia Pathogens: The Ten Year Report from the European SENTRY Antimicrobial Surveillance Program, Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

High-Level Multidrug-Resistance (MDR) Among Viridians Group Streptococci Isolated from Turkey: Report from the SENTRY Antimicrobial Surveillance Program

High-Level Multidrug-Resistance (MDR) Among Viridians Group Streptococci Isolated from Turkey: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Biedenbach DJ, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Activity of Ceftobiprole Tested Against Contemporary European Enterobacteriaceae and Pseudomonas aeruginosa (2005-2006)

Activity of Ceftobiprole Tested Against Contemporary European Enterobacteriaceae and Pseudomonas aeruginosa (2005-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany

Activity of Ceftobiprole Tested Against Staphylococcal and Streptococcal Isolates Recovered from Patients in European Medical Centers (2005-2006)

Activity of Ceftobiprole Tested Against Staphylococcal and Streptococcal Isolates Recovered from Patients in European Medical Centers (2005-2006), Lead author: Fritsche TR, presented at 17th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31 – April 3, 2007, Munich, Germany